588 related articles for article (PubMed ID: 11123360)
1. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors.
Movsesyan VA; O'Leary DM; Fan L; Bao W; Mullins PG; Knoblach SM; Faden AI
J Pharmacol Exp Ther; 2001 Jan; 296(1):41-7. PubMed ID: 11123360
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
Lea PM; Movsesyan VA; Faden AI
Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
[TBL] [Abstract][Full Text] [Related]
3. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism.
O'Leary DM; Movsesyan V; Vicini S; Faden AI
Br J Pharmacol; 2000 Dec; 131(7):1429-37. PubMed ID: 11090117
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.
Bruno V; Ksiazek I; Battaglia G; Lukic S; Leonhardt T; Sauer D; Gasparini F; Kuhn R; Nicoletti F; Flor PJ
Neuropharmacology; 2000 Sep; 39(12):2223-30. PubMed ID: 10974306
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of the mGluR1 receptor reduces traumatic neuronal injury in vitro and improvesoOutcome after brain trauma.
Faden AI; O'Leary DM; Fan L; Bao W; Mullins PG; Movsesyan VA
Exp Neurol; 2001 Feb; 167(2):435-44. PubMed ID: 11161632
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid-induced striatal toxicity: involvement of pre- and post-synaptic mechanisms and lack of direct NMDA blocking activity.
Popoli P; Pintor A; Tebano MT; Frank C; Pepponi R; Nazzicone V; Grieco R; Pèzzola A; Reggio R; Minghetti L; De Berardinis MA; Martire A; Potenza RL; Domenici MR; Massotti M
J Neurochem; 2004 Jun; 89(6):1479-89. PubMed ID: 15189351
[TBL] [Abstract][Full Text] [Related]
7. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.
Campbell UC; Lalwani K; Hernandez L; Kinney GG; Conn PJ; Bristow LJ
Psychopharmacology (Berl); 2004 Sep; 175(3):310-8. PubMed ID: 15024550
[TBL] [Abstract][Full Text] [Related]
8. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
Bao WL; Williams AJ; Faden AI; Tortella FC
Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice.
Kozela E; Pilc A; Popik P
Psychopharmacology (Berl); 2003 Jan; 165(3):245-51. PubMed ID: 12442203
[TBL] [Abstract][Full Text] [Related]
10. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
11. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties.
Swedberg MD; Ellgren M; Raboisson P
J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725
[TBL] [Abstract][Full Text] [Related]
12. Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury.
Allen JW; Ivanova SA; Fan L; Espey MG; Basile AS; Faden AI
J Pharmacol Exp Ther; 1999 Jul; 290(1):112-20. PubMed ID: 10381766
[TBL] [Abstract][Full Text] [Related]
13. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
Gasparini F; Lingenhöhl K; Stoehr N; Flor PJ; Heinrich M; Vranesic I; Biollaz M; Allgeier H; Heckendorn R; Urwyler S; Varney MA; Johnson EC; Hess SD; Rao SP; Sacaan AI; Santori EM; Veliçelebi G; Kuhn R
Neuropharmacology; 1999 Oct; 38(10):1493-503. PubMed ID: 10530811
[TBL] [Abstract][Full Text] [Related]
14. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease.
Armentero MT; Fancellu R; Nappi G; Bramanti P; Blandini F
Neurobiol Dis; 2006 Apr; 22(1):1-9. PubMed ID: 16289868
[TBL] [Abstract][Full Text] [Related]
15. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine.
Lee B; Platt DM; Rowlett JK; Adewale AS; Spealman RD
J Pharmacol Exp Ther; 2005 Mar; 312(3):1232-40. PubMed ID: 15550570
[TBL] [Abstract][Full Text] [Related]
17. MGLuR5 activation reduces beta-amyloid-induced cell death in primary neuronal cultures and attenuates translocation of cytochrome c and apoptosis-inducing factor.
Movsesyan VA; Stoica BA; Faden AI
J Neurochem; 2004 Jun; 89(6):1528-36. PubMed ID: 15189356
[TBL] [Abstract][Full Text] [Related]
18. SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.
Varney MA; Cosford ND; Jachec C; Rao SP; Sacaan A; Lin FF; Bleicher L; Santori EM; Flor PJ; Allgeier H; Gasparini F; Kuhn R; Hess SD; Veliçelebi G; Johnson EC
J Pharmacol Exp Ther; 1999 Jul; 290(1):170-81. PubMed ID: 10381773
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats.
Jesse CR; Savegnago L; Rocha JB; Nogueira CW
Brain Res; 2008 Mar; 1198():197-203. PubMed ID: 18242586
[TBL] [Abstract][Full Text] [Related]
20. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release.
Homayoun H; Stefani MR; Adams BW; Tamagan GD; Moghaddam B
Neuropsychopharmacology; 2004 Jul; 29(7):1259-69. PubMed ID: 15010696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
